Latest Development Program News

PC Gold has reported high-grade gold intercepts extending the Main Zone at Spring Hill by 120 metres south, with mineralisation now found within the existing pit shell and drilling ramping up to accelerate resource growth ahead of a June update.

Evion Group has secured key approvals from Madagascar’s Ministry of Mines to convert exploration permits into mining permits for its Maniry Graphite Project, backed by significant EU funding and US trade initiatives. Meanwhile, its Indian joint venture progresses a major graphite plant expansion to meet growing demand.

Atomic Eagle Limited has boosted its Muntanga Uranium Project resources by 24%, declared a maiden Ore Reserve, and confirmed project viability through an independent engineering review, setting the stage for a major drilling campaign.

HyTerra Ltd is progressing its flagship Nemaha hydrogen project with a key production test planned for Q2 2026, while expanding its global footprint through strategic partnerships and a $7 million capital raise.

Sky Metals has bolstered its cash reserves with a $20.5 million raise, backing a major drilling push at Tallebung and expanding exploration at Doradilla, positioning both projects for significant resource growth and development progress.

West Coast Silver has confirmed a substantial high-grade silver resource at Elizabeth Hill, supported by exceptional drill results and a maiden Mineral Resource Estimate, setting the stage for accelerated development.

Red Sky Energy bolsters its Innamincka Dome operations with binding AFEs for new wells and a $5.2 million capital raise, targeting near-term production growth and cashflow.

Australis Oil & Gas has partnered with a major US-listed company to develop its Tuscaloosa Marine Shale assets, retaining a 10% interest in producing wells and holding a strong cash position after recent transactions.

Golden Horse Minerals delivered robust drilling results at Southern Cross in Q1 2026, including visible gold at depth and strong shallow intercepts, supported by a healthy cash reserve of $39.3 million.

Cleo Diagnostics has kicked off a staged manufacturing program with Bio-Techne to produce ovarian cancer test kits, moving from clinical sample collection to analytical validation and FDA submission preparation.

Island Pharmaceuticals has cleared a major regulatory hurdle with the US FDA, confirming a clinical development path for its antiviral Galidesivir under the Animal Rule. Backed by a $9 million capital raise and strategic partnerships, the company is poised for potential US government procurement and biodefence market entry.

Bellavista Resources has cleared all hurdles to complete its takeover of Auteco Minerals, securing a majority stake in the Pickle Crow Gold Project in Ontario. The company also moves to settle the second tranche of its $35 million capital raise, underpinning its Canadian expansion plans.